Inside Precision Medicine·4 min read·hard
GLP-1 Treated Patients with Diabetes Have Raised Risk for Eye Condition
H
Helen Albert
✦AI Summary
A new study suggests that patients with type 2 diabetes using GLP-1 receptor agonists may have a slightly higher risk of developing ischemic optic neuropathy. While the absolute risk remains low, researchers observed a higher incidence compared to other diabetes medications.
A large study of people with type 2 diabetes suggests that those who started treatment with a glucagon‑like peptide (GLP)‑1 receptor agonist after diagnosis had slightly increased risk of developing a serious eye condition called ischemic optic neuropathy than people with diabetes treated with other medications.
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in